XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 568,505 $ 1,336,883
Restricted cash 10,424 10,303
Accounts receivable 297,240 82,375
Inventory 41,696 36,683
Prepaid expenses and other current assets 226,023 237,147
Total current assets 1,143,888 1,703,391
Property and equipment, net 305,771 294,247
Right of use asset, net 185,218 106,241
Goodwill 127,454 126,331
Other non-current assets 35,159 28,469
Total assets 1,797,490 2,258,679
Current liabilities:    
Accounts payable 132,610 216,517
Accrued expenses 394,668 591,158
Deferred revenue 241,310 370,137
Current portion of finance lease liabilities 5,142 27,196
Convertible notes payable 0 324,881
Other current liabilities 861,408 930,055
Total current liabilities 1,635,138 2,459,944
Deferred revenue 622,210 179,414
Convertible notes payable 168,016 166,466
Non-current finance lease liabilities 55,923 31,238
Other non-current liabilities 33,130 55,695
Total liabilities 2,514,417 2,892,757
Commitments and contingencies (Note 16)
Preferred stock, $0.01 par value, 2,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022 0 0
Stockholders’ deficit:    
Common stock, $0.01 par value, 600,000,000 shares authorized at December 31, 2023 and 2022; and 140,506,093 shares issued and 139,505,770 shares outstanding at December 31, 2023 and 86,806,554 shares issued and 86,039,923 shares outstanding at December 31, 2022 1,405 868
Additional paid-in capital 4,192,164 3,737,979
Accumulated deficit (4,820,951) (4,275,889)
Treasury stock, 1,000,323 shares, cost basis at December 31, 2023 and 766,631 shares, cost basis at December 31, 2022 (92,267) (90,659)
Accumulated other comprehensive income (loss) 2,722 (6,377)
Total stockholders’ deficit (716,927) (634,078)
Total liabilities and stockholders’ deficit $ 1,797,490 $ 2,258,679